Misincorporation of nucleotides opposite five-membered exocyclic ring guanine derivatives by escherichia coli polymerases in vitro and in vivo: 1,N2-ethenoguanine, 5,6,7,9-tetrahydro-9-oxoimidazo[1, 2-a]purine, and 5,6,7,9-tetrahydro-7-hydroxy-9-oxoimidazo[1, 2-a]purine

Biochemistry
S LangouëtF P Guengerich

Abstract

A variety of exocyclic modified bases have been shown to be formed in DNA from various procarcinogens (e.g., acrolein, malonaldehyde, vinyl chloride, urethan) and are also found in untreated animals and humans, presumably arising as a result of lipid peroxidation. 1, N2-Ethenoguanine (1,N2-epsilon-Gua), a product known to be formed from several 2-carbon electrophiles, was placed in a known site (6256) in bacteriophage M13MB19 and mutations were analyzed in Escherichia coli, with 2.05% G-->A, 0.74% G-->T, and 0.09% G-->C changes found in uvrA- bacteria. 5,6,7, 9-Tetrahydro-7-hydroxy-9-oxoimidazo[1,2-a]purine (HO-ethanoGua), formally the hydrated derivative of 1,N2-epsilon-Gua, is a stable DNA product also derived from vinyl halides. When this base was placed in the same context, the mutation rate was 0.007-0.19% for G-->A, C, or T changes. The saturated etheno ring derivative of 1, N2-epsilon-Gua, 5,6,7,9-tetrahydro-9-oxoimidazo[1,2-a]purine (ethanoGua) produced G-->A and G-->T mutations (0.71% each). All mutants were SOS-dependent and were attenuated by uvrA activity in E. coli. In vitro studies with four polymerases showed strong blocks to addition beyond the adduct site in the order ethanoGua > HO-ethanoGua > 1,N2-epsilon-Gua...Continue Reading

Citations

Jun 20, 2006·Chemical Research in Toxicology·Jeong-Yun ChoiF Peter Guengerich
Jul 31, 2007·Chemical Research in Toxicology·Min Young KimGerald N Wogan
Oct 19, 2007·Chemical Research in Toxicology·Ganesh ShanmugamMichael P Stone
Nov 14, 2000·Journal of Bacteriology·G A PandyaM Moriya
Jan 20, 2012·Free Radical Research·Alicja WinczuraBarbara Tudek
Feb 28, 2004·FEBS Letters·Sabrina A MarquesMarisa H G Medeiros
Nov 21, 2007·Journal of Molecular Biology·Alexandra DimitriDavid A Scicchitano
Dec 3, 2016·Free Radical Biology & Medicine·Barbara TudekElżbieta Speina
Oct 23, 2004·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Bo Hang
Feb 4, 2005·Environmental and Molecular Mutagenesis·Priscilla H FernandesR Stephen Lloyd
Aug 1, 2002·Current Protocols in Toxicology·James A SwenbergPatricia B Upton
Dec 29, 2019·The Journal of Biological Chemistry·Adam Z Thelen, Patrick J O'Brien
Feb 26, 2000·Carcinogenesis·L J Marnett
Dec 17, 2000·The Journal of Biological Chemistry·L A VanderVeenL J Marnett
Jan 25, 2018·Journal of Clinical Biochemistry and Nutrition·Yoshichika Kawai, Erika Nuka
Oct 9, 1998·The Journal of Biological Chemistry·P PourquierY Pommier
Jan 25, 2021·The Journal of Biological Chemistry·Adam Z Thelen, Patrick J O'Brien
Aug 13, 2008·Chemical Research in Toxicology·Ganesh ShanmugamMichael P Stone
Feb 9, 2006·Chemical Reviews·F Peter Guengerich
Jun 17, 2021·Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society·F Peter Guengerich, Pratibha P Ghodke
Jun 16, 1999·Chemical Research in Toxicology·S Akasaka, F P Guengerich
Jun 17, 2003·Chemical Research in Toxicology·Yanhe HuangFrancis Johnson
Jul 18, 2000·Chemical Research in Toxicology·A P LoureiroM H Medeiros

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.